Legis Daily

Coronavirus EGC Extension Act

USA116th CongressHR-7661| House 
| Updated: 7/16/2020
Bryan Steil

Bryan Steil

Republican Representative

Wisconsin

Cosponsors (2)
Steve Stivers (Republican)J. French Hill (Republican)

Financial Services Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Coronavirus EGC Extension Act This bill extends the status of an issuer of securities as an emerging growth company. Specifically, these issuers will remain emerging growth companies until the later of one year after the date of enactment of this bill, the end of the COVID-19 (i.e., coronavirus disease 2019) emergency declaration period, and the date the issuer would otherwise cease being an emerging growth company. Emerging growth companies (in general, a newly public company with revenues below a specified threshold) are subject to reduced disclosure requirements, among other regulations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 16, 2020
Introduced in House
Jul 16, 2020
Referred to the House Committee on Financial Services.
Jul 20, 2020

Latest Companion Bill Action

S 116-4218
Introduced in Senate
  • July 16, 2020
    Introduced in House


  • July 16, 2020
    Referred to the House Committee on Financial Services.


  • July 20, 2020

    Latest Companion Bill Action

    S 116-4218
    Introduced in Senate

Finance and Financial Sector

Related Bills

  • S 116-4218: Coronavirus EGC Extension Act
Accounting and auditingBusiness investment and capitalCardiovascular and respiratory healthCorporate finance and managementEmergency medical services and trauma careGovernment information and archivesInfectious and parasitic diseasesSecuritiesSmall businessWages and earnings

Coronavirus EGC Extension Act

USA116th CongressHR-7661| House 
| Updated: 7/16/2020
Coronavirus EGC Extension Act This bill extends the status of an issuer of securities as an emerging growth company. Specifically, these issuers will remain emerging growth companies until the later of one year after the date of enactment of this bill, the end of the COVID-19 (i.e., coronavirus disease 2019) emergency declaration period, and the date the issuer would otherwise cease being an emerging growth company. Emerging growth companies (in general, a newly public company with revenues below a specified threshold) are subject to reduced disclosure requirements, among other regulations.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 16, 2020
Introduced in House
Jul 16, 2020
Referred to the House Committee on Financial Services.
Jul 20, 2020

Latest Companion Bill Action

S 116-4218
Introduced in Senate
  • July 16, 2020
    Introduced in House


  • July 16, 2020
    Referred to the House Committee on Financial Services.


  • July 20, 2020

    Latest Companion Bill Action

    S 116-4218
    Introduced in Senate
Bryan Steil

Bryan Steil

Republican Representative

Wisconsin

Cosponsors (2)
Steve Stivers (Republican)J. French Hill (Republican)

Financial Services Committee

Finance and Financial Sector

Related Bills

  • S 116-4218: Coronavirus EGC Extension Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Accounting and auditingBusiness investment and capitalCardiovascular and respiratory healthCorporate finance and managementEmergency medical services and trauma careGovernment information and archivesInfectious and parasitic diseasesSecuritiesSmall businessWages and earnings